Suchergebnisse - "Douxfils, Jonathan"

PubPharm (11)

1

Importance of measuring pharmacologically active metabolites of edoxaban : development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method

enthalten in: Journal of thrombosis and thrombolysis | 2020

von Siriez, R. | Alpan, L. | Elasaad, K. | +4

2

Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial

enthalten in: Thrombosis and haemostasis | 2020

von Harenberg, J. | Beyer-Westendorf, J. | Crowther, M. | +41

CommentIn: Thromb Haemost. 2020 Jan;120(1):11-13. - PMID 31752043

3

Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma

enthalten in: International journal of laboratory hematology | 2019

von Siriez, R. | Evrard, J. | Dogné, J. | +5

4

Betrixaban : Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide

enthalten in: Thrombosis and haemostasis | 2018

von Siriez, R. | Evrard, J. | Dogné, J. | +5

5

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

enthalten in: Thrombosis and haemostasis | 2018

von Gosselin, R. | Adcock, D. | Bates, S. | +7

6

Measuring Direct Oral Anticoagulants

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2017

von Gosselin, R. | Douxfils, J.

7

Edoxaban : Impact on routine and specific coagulation assays. A practical laboratory guide

enthalten in: Thrombosis and haemostasis | 2016

von Douxfils, J. | Chatelain, B. | Chatelain, C. | +2

8

Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply

enthalten in: The Annals of pharmacotherapy | 2015

von Larock, A. | Mullier, F. | Douxfils, J. | +2

CommentOn: Ann Pharmacother. 2014 Oct;48(10):1258-68. - PMID 24982310

9

Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation : a prospective study

enthalten in: The Annals of pharmacotherapy | 2014

von Larock, A. | Mullier, F. | Sennesael, A. | +5

CommentIn: Ann Pharmacother. 2015 Jan;49(1):154. - PMID 25524932

10

Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Journal of the American Heart Association | 2014

von Douxfils, J. | Buckinx, F. | Mullier, F. | +6